Revue medicale suisse最新文献

筛选
英文 中文
[Anesthesiology : a little-known but necessary specialty for everyone].
Revue medicale suisse Pub Date : 2025-03-19 DOI: 10.53738/REVMED.2025.21.910.563
Laurène Ibanez, Sina Grape, Annouk Perret Morisoli
{"title":"[Anesthesiology : a little-known but necessary specialty for everyone].","authors":"Laurène Ibanez, Sina Grape, Annouk Perret Morisoli","doi":"10.53738/REVMED.2025.21.910.563","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.910.563","url":null,"abstract":"<p><p>The field of anesthesiology is rapidly evolving and expanding. With the growth of perioperative medicine, anesthesiologists are now involved throughout the entire patient's surgical journey. In parallel, technological advances such as ultrasound and high-flow oxygen administration, as well as the introduction of new drugs, have driven innovation. In addition, existing guidelines are being reevaluated, requiring adjustments in daily clinical practice. For instance, fasting rules are becoming more flexible and the need for preoperative examinations is decreasing. This article aims to provide an update on the major advances in anesthesiology.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 910","pages":"563-567"},"PeriodicalIF":0.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Falls and atrial fibrillation in elderly patients].
Revue medicale suisse Pub Date : 2025-03-19 DOI: 10.53738/REVMED.2025.21.910.557
Catherine Belley, Marc Arcens, Nicolas Johner, Sarah Mauler-Wittwer, Stéphane Noble
{"title":"[Falls and atrial fibrillation in elderly patients].","authors":"Catherine Belley, Marc Arcens, Nicolas Johner, Sarah Mauler-Wittwer, Stéphane Noble","doi":"10.53738/REVMED.2025.21.910.557","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.910.557","url":null,"abstract":"<p><p>In elderly patients prone to multiple falls with atrial fibrillation, anticoagulants are often discontinued, primarily due to fear of bleeding. However, even in the presence of repeated falls, the increased risk of stroke associated with discontinuation of anticoagulation significantly outweighs the hemorrhagic risk. The management of fall-prone patients with atrial fibrillation relies on oral anticoagulation along with a systematic assessment of risk factors for bleeding to identify and treat modifiable risk factors. Left atrial appendage closure represents an alternative to anticoagulation that may be considered in cases of irreversible cause of intracerebral hemorrhage and non-modifiable risk factors.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 910","pages":"557-562"},"PeriodicalIF":0.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Déprescription des inhibiteurs de la pompe à protons.
Revue medicale suisse Pub Date : 2025-03-19 DOI: 10.53738/REVMED.2025.21.910.552
Omar Kherad
{"title":"Déprescription des inhibiteurs de la pompe à protons.","authors":"Omar Kherad","doi":"10.53738/REVMED.2025.21.910.552","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.910.552","url":null,"abstract":"","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 910","pages":"552"},"PeriodicalIF":0.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[New anti-obesity medications. Prescription and follow-up].
Revue medicale suisse Pub Date : 2025-03-19 DOI: 10.53738/REVMED.2025.21.910.522
Zoltan Pataky, Florence Somers, Marie-Luce Guillermain-Spahr, Frank Habicht, Jorge César Correia, François Pralong
{"title":"[New anti-obesity medications. Prescription and follow-up].","authors":"Zoltan Pataky, Florence Somers, Marie-Luce Guillermain-Spahr, Frank Habicht, Jorge César Correia, François Pralong","doi":"10.53738/REVMED.2025.21.910.522","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.910.522","url":null,"abstract":"<p><p>The treatment of obesity is complex and relies on interdisciplinary follow-up. The new medications promote weight loss without addressing the underlying causes of overweight or obesity. Medication alone, without an interdisciplinary approach, can be detrimental to the patient due to the significant risk of therapeutic failure. These medications do not meet the reimbursement criteria, and the prescribing physician must submit a request for reimbursement authorization and periodically report to the health insurance. The initiation, follow-up, and discontinuation of pharmacological treatment of obesity must be undertaken in partnership between the person living with obesity and the obesity specialist.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 910","pages":"522-526"},"PeriodicalIF":0.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pharmacological treatments for obesity : what does the future hold?]
Revue medicale suisse Pub Date : 2025-03-19 DOI: 10.53738/REVMED.2025.21.910.542
Jorge César Correia, Florence Somers, Zoltan Pataky
{"title":"[Pharmacological treatments for obesity : what does the future hold?]","authors":"Jorge César Correia, Florence Somers, Zoltan Pataky","doi":"10.53738/REVMED.2025.21.910.542","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.910.542","url":null,"abstract":"<p><p>Recent pharmacological advances, illustrated by molecules such as semaglutide 2,4 mg and tirzepatide, have transformed the management of obesity. New innovative molecules, based in particular on key entero-pancreatic hormones such as glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, glucagon, and amylin, are currently being studied as monotherapies or in various combinations. Other therapies targeting other pathways, such as the leptin-melanocortin pathway, are also in development. Initial results regarding weight loss are promising, but long-term studies are needed to assess their safety and lasting efficacy. These medications must be part of an overall management approach in which lifestyle changes remain essential to ensure lasting, optimal results.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 910","pages":"542-546"},"PeriodicalIF":0.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Système de santé : ne pas se tromper de bataille.
Revue medicale suisse Pub Date : 2025-03-19 DOI: 10.53738/REVMED.2025.21.910.576
Stéfanie Monod
{"title":"Système de santé : ne pas se tromper de bataille.","authors":"Stéfanie Monod","doi":"10.53738/REVMED.2025.21.910.576","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.910.576","url":null,"abstract":"","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 910","pages":"576"},"PeriodicalIF":0.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Management of peripheral arterial disease. Summary of the new European guidelines].
Revue medicale suisse Pub Date : 2025-03-19 DOI: 10.53738/REVMED.2025.21.910.553
Lucia Mazzolai, Adriano Alatri, Luca Calanca, Stefano Lanzi
{"title":"[Management of peripheral arterial disease. Summary of the new European guidelines].","authors":"Lucia Mazzolai, Adriano Alatri, Luca Calanca, Stefano Lanzi","doi":"10.53738/REVMED.2025.21.910.553","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.910.553","url":null,"abstract":"<p><p>New European guidelines for the management of peripheral arterial disease emphasize a comprehensive approach focusing on prevention, diagnosis, treatment and follow-up. Cardiovascular risk factors, such as smoking, high cholesterol, hypertension and diabetes, must be managed by lifestyle changes and medications such as statins, antiplatelet agents and, in some cases, anticoagulants. Diagnosis is based on the ankle-arm pressure index, with ultrasound as the first imaging modality. For intermittent claudication, supervised exercise is recommended. Revascularization is considered if symptoms persist after optimal treatment.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 910","pages":"553-556"},"PeriodicalIF":0.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Some key points for understanding a transthoracic ultrasound report].
Revue medicale suisse Pub Date : 2025-03-19 DOI: 10.53738/REVMED.2025.21.910.568
Alexandra Lafitte, Stéphane Mouraux, Henri Lu, Pierre Monney
{"title":"[Some key points for understanding a transthoracic ultrasound report].","authors":"Alexandra Lafitte, Stéphane Mouraux, Henri Lu, Pierre Monney","doi":"10.53738/REVMED.2025.21.910.568","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.910.568","url":null,"abstract":"<p><p>Transthoracic echocardiography (TTE) is one of the most performed cardiac examinations in internal medicine. It enables a quantitative evaluation of the cardiac morphology and function based on diameters, volumes and/or intracardiac blood flow velocity measurements. These measurements are systematically interpreted by a cardiologist and summarized into a concise and objective description that is useful for clinical management. The detail of all the quantitative measures is complex and usually hard to be directly interpreted by a non-cardiologist. This article illustrates the utility of TTE in four frequent in-hospital clinical situations, underlining not only the strengths, but also the limitations associated with this examination.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 910","pages":"568-573"},"PeriodicalIF":0.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The right treatment at the right time. A new program for people with obesity].
Revue medicale suisse Pub Date : 2025-03-19 DOI: 10.53738/REVMED.2025.21.910.547
Florence Somers, Anna Toumanova, Jorge César Correia, Zoltan Pataky
{"title":"[The right treatment at the right time. A new program for people with obesity].","authors":"Florence Somers, Anna Toumanova, Jorge César Correia, Zoltan Pataky","doi":"10.53738/REVMED.2025.21.910.547","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.910.547","url":null,"abstract":"<p><p>Against the backdrop of the obesity pandemic, treating obesity and reducing its complications is a major health challenge. The revolution in the new treatments of obesity represents a powerful tool to meet this challenge with less risk. As a result, the demand for overinvested medications has exploded. The impatience of concerned people to receive such treatments jeopardizes the therapeutic relationship. To find a way out of this predicament, the interdisciplinary team of the Therapeutic Patient Education Unit at the University Hospitals of Geneva has implemented a new therapeutic program for obesity management. It is based on peer sharing, a motivational approach, reflection on the skills to develop to initiate medication, and key learnings, and aims for sustained commitment to behavior change to achieve long-term weight loss.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 910","pages":"547-550"},"PeriodicalIF":0.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Faut-il encore culpabiliser devant son espresso ?
Revue medicale suisse Pub Date : 2025-03-19 DOI: 10.53738/REVMED.2025.21.910.575
Loris Canton
{"title":"Faut-il encore culpabiliser devant son espresso ?","authors":"Loris Canton","doi":"10.53738/REVMED.2025.21.910.575","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.910.575","url":null,"abstract":"","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 910","pages":"575"},"PeriodicalIF":0.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信